Histone Deacetylase Inhibitors as Anticancer Drugs

Tomáš Eckschlager(Charles University), Jan Hraběta(Charles University)

International Journal of Molecular Sciences

July 1, 2017

10.3390/ijms18071414

Cited by 1,170

Related Papers

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances

|Pharmacology & Therapeutics|2011|151

Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes

|Scientific Reports|2016|26

Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma

|PLoS ONE|2016|24

Electrochemical and computational study of doxorubicininteractions with DNA

|Unknown|2009|1